Home/Vandria/Pénélope Andreux, PharmD, PhD
PA

Pénélope Andreux, PharmD, PhD

Chief Scientific Officer

Vandria

Vandria Pipeline

DrugIndicationPhase
VNA-318Cognitive Impairment (Alzheimer's Disease, Major Depressive Disorder)Phase 1